This clinical trial evaluates the effectiveness of amniotic membrane application during cesarean delivery in reducing post-surgical complications and improving wound healing and cosmetic outcomes in women aged 18-40 undergoing their first cesarean section. The primary questions this study aims to answer are: 1. Compared to standard care, Does the amniotic membrane reduce surgical site infections and wound dehiscence? 2. Does the amniotic membrane improve patient satisfaction with cosmetic outcomes? Participants were randomized into two groups: the intervention group received an amniotic membrane application over the cesarean incision site, while the control group underwent cesarean delivery without membrane application. Outcomes were assessed at predefined postoperative intervals, focusing on wound healing, pain levels, and cosmetic satisfaction.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Surgical Site Infection (SSI)
Timeframe: Time Frame: Within 7 days post-surgery.
Wound Dehiscence
Timeframe: Time Frame: Within 7 days post-surgery.
Scar/Keloid Formation
Timeframe: Time Frame: At 40 days and 6 months post-surgery.